The correlations between the fractions of tumor-infiltrating immune cells and STAT5-associated signature risk scores were assessed by Spearman correlation analysis in the training cohort (GSE37642-GPL96) and seven other cohorts (Figure 4A). The gene discussed is STAT5B; the disease is neoplasm.